We retrospectively investigated the efficacy and feasibility of concurrent chemoradiotherapy
for patients with severe dysphagia caused by oesophageal squamous cell carcinoma …

PURPOSE: To investigate the efficacy and feasibility of concurrent chemoradiotherapy for
locally advanced carcinoma of the esophagus. PATIENTS AND METHODS: Fifty-four …

Thirty‐five patients with nonmetastatic squamous cell carcinoma of the esophagus were
treated with chemotherapy (5‐fluorouracil, cisplatin) and concomitant split‐course radiation …

Abstract Background and Objectives Since the prognosis of patients with T4 squamous cell
carcinoma (SCC) of the esophagus is extremely poor, an effective multimodal treatment …

BACKGROUND AND PURPOSE: Following our phase II experience, a randomised trial was
undertaken to evaluate the efficacy of adding chemotherapy to radiotherapy in patients with …

Background. For patients with unresectable non‐metastatic squamous cell carcinoma of the
esophagus (SCCE), the conventional treatment has been radiation therapy (RT). Because …

We performed a retrospective study of 90 consecutive cases with inoperable carcinoma of
the oesophagus treated with definitive chemoradiation at a single cancer centre between …

This study was performed to assess the efficacy and safety of docetaxel, cisplatin and
fluorouracil combination in patients with unresectable locally advanced oesophageal …

This randomized clinical study was to assess and compare the efficacy and safety of two
chemoradiotherapy (cisplatin+ 5-fluorouracil+ radiotherapy and cisplatin+ docetaxel+ …

We evaluated the feasibility of six courses of chemotherapy in 34 consecutive patients with
localised squamous cell carcinoma of the oesophagus. All 32 evaluable patients first …